WO2002069911A3 - WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN - Google Patents

WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN Download PDF

Info

Publication number
WO2002069911A3
WO2002069911A3 PCT/EP2002/002321 EP0202321W WO02069911A3 WO 2002069911 A3 WO2002069911 A3 WO 2002069911A3 EP 0202321 W EP0202321 W EP 0202321W WO 02069911 A3 WO02069911 A3 WO 02069911A3
Authority
WO
WIPO (PCT)
Prior art keywords
bioquinones
active substance
combination consisting
substance combination
liponic acid
Prior art date
Application number
PCT/EP2002/002321
Other languages
English (en)
French (fr)
Other versions
WO2002069911A2 (de
Inventor
Thomas Raschke
Uwe Schoenrock
Nadine Voigt
Original Assignee
Beiersdorf Ag
Thomas Raschke
Uwe Schoenrock
Nadine Voigt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag, Thomas Raschke, Uwe Schoenrock, Nadine Voigt filed Critical Beiersdorf Ag
Publication of WO2002069911A2 publication Critical patent/WO2002069911A2/de
Publication of WO2002069911A3 publication Critical patent/WO2002069911A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Wirkstoffkombinationen aus (a) α-Liponsäure und (b) einem oder mehreren Biochinonen.
PCT/EP2002/002321 2001-03-06 2002-03-04 WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN WO2002069911A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10111053.7 2001-03-06
DE10111053A DE10111053A1 (de) 2001-03-06 2001-03-06 Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen

Publications (2)

Publication Number Publication Date
WO2002069911A2 WO2002069911A2 (de) 2002-09-12
WO2002069911A3 true WO2002069911A3 (de) 2002-12-27

Family

ID=7676670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/002321 WO2002069911A2 (de) 2001-03-06 2002-03-04 WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN

Country Status (2)

Country Link
DE (1) DE10111053A1 (de)
WO (1) WO2002069911A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106133A1 (de) * 2001-02-10 2002-08-14 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Emulsionen, mit einem Gehalt an Polyoxyethylen(20)cetylstearylether und hydrophoben anorganischen Mikropigmenten
EP2740492A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Triazinformulierungen, einen weiteren Wirkstoff und Tensid(e) enthaltend
CN107789660A (zh) * 2016-08-31 2018-03-13 杜建 一种用于皮肤及软组织损伤的医用敷料

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654373A (en) * 1982-03-19 1987-03-31 Italfarmaco S.A. Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
WO1997010808A1 (en) * 1995-09-20 1997-03-27 Perricone Nicholas V Lipoic acid in topical compositions
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6048886A (en) * 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
WO2000053176A1 (en) * 1999-03-05 2000-09-14 Uni-Ci S.R.L. Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
EP1072265A1 (de) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Verwendung von pflanzlichen Polyphenolen zur Behandlug von Eisenüberschuss
WO2001009000A1 (en) * 1999-08-03 2001-02-08 Giorgio Panin A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
EP1084701A1 (de) * 1999-09-15 2001-03-21 Beiersdorf Aktiengesellschaft O/W-Emulsion mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerina
DE10032964A1 (de) * 2000-07-06 2002-01-24 Beiersdorf Ag Verwendung von Kreatin und/oder Kreatingderivaten in kosmetischen oder dermatologischen Zubereitungen
EP1175898A2 (de) * 2000-07-28 2002-01-30 Beiersdorf Aktiengesellschaft Kosmetische oder dermatologische Verwendung von Kombinationen mit einem Gehalt an Carnitinen
WO2002011717A1 (en) * 2000-08-07 2002-02-14 Juvenon, Inc. Cosmetics to support skin metabolism

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19926167B4 (de) * 1999-06-09 2012-08-30 Henkel Ag & Co. Kgaa Aerosol-Stylingmittel auf Wasserbasis mit Biochinonen
DE19926168A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Stylingmittel auf Alkoholbasis mit Biochinonen
DE19926170A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Haarkosmetische Mittel mit Ubichinonen
DE19931308A1 (de) * 1999-07-07 2001-01-11 Beiersdorf Ag Desodorierende und/oder antitranspirierend wirkende Zubereitungen mit einem Gehalt an Biochinonen
KR20030016202A (ko) * 1999-11-24 2003-02-26 액세스 비지니스 그룹 인터내셔날 엘엘씨 국소성 피부 조성물
CA2399319A1 (en) * 2000-01-25 2001-08-16 Nathan D. Hamilton Nutritional supplements for aged pets

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654373A (en) * 1982-03-19 1987-03-31 Italfarmaco S.A. Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
WO1997010808A1 (en) * 1995-09-20 1997-03-27 Perricone Nicholas V Lipoic acid in topical compositions
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6048886A (en) * 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
WO2000053176A1 (en) * 1999-03-05 2000-09-14 Uni-Ci S.R.L. Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
EP1072265A1 (de) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Verwendung von pflanzlichen Polyphenolen zur Behandlug von Eisenüberschuss
WO2001009000A1 (en) * 1999-08-03 2001-02-08 Giorgio Panin A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
EP1084701A1 (de) * 1999-09-15 2001-03-21 Beiersdorf Aktiengesellschaft O/W-Emulsion mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerina
DE10032964A1 (de) * 2000-07-06 2002-01-24 Beiersdorf Ag Verwendung von Kreatin und/oder Kreatingderivaten in kosmetischen oder dermatologischen Zubereitungen
EP1175898A2 (de) * 2000-07-28 2002-01-30 Beiersdorf Aktiengesellschaft Kosmetische oder dermatologische Verwendung von Kombinationen mit einem Gehalt an Carnitinen
WO2002011717A1 (en) * 2000-08-07 2002-02-14 Juvenon, Inc. Cosmetics to support skin metabolism

Also Published As

Publication number Publication date
DE10111053A1 (de) 2002-09-12
WO2002069911A2 (de) 2002-09-12

Similar Documents

Publication Publication Date Title
MXPA03007816A (es) Calzoncillo desechable y metodo para proporcionar el mismo.
AU2002253619A1 (en) Heterocyclic compound and antitumor agent containing the same active ingredients
MX255941B (es) Derivado de isoxazolina y herbicida que lo contiene como ingrediente activo.
PL368233A1 (en) Selective herbicides based on substituted cyclic keto-enols and safeners
WO2003012119A3 (en) Nucleic acid amplification method
WO2004082454A3 (de) Endovaskuläres implantat mit einer zumindest abschnittsweisen aktiven beschichtung aus ratjadon und/oder einem ratjadon-derivat
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
AU2002366286A1 (en) Microencapsulated insecticide
EG23184A (en) Targeting system and method of targeting.
ZA200401401B (en) Fungicide active substance combinations.
MXPA04002001A (es) Procedimiento para entresacado de frutos.
EP1326306A3 (de) Anschlusselement für ein Flachbandkabel und Verfahren zur Verbindung des Anschlusselementes am Flachbandkabel
WO2002069911A3 (de) WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND BIOCHINONEN
WO2003009190A8 (de) Verfahren zur gewährung von rabatten auf produkte und/oder dienstleistungen
AU2002361096A1 (en) Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
AU2002234560A1 (en) Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides
EP1018336A4 (de) Karzinostatika
EP1571148A4 (de) 3-phenylcinnolinhomologon und dieses enthaltendes antitumormittel
AU2002250977A1 (en) Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol
AU2001233002A1 (en) Etching solution and method
AU2002348869A1 (en) Integrated circuit with an amplifier
AU2002332286A1 (en) Water-soluble phenylpyridazine derivatives and medicines containing the same
AU2001240128A1 (en) Method of conducting secure clinical trials and guaranteeing the occurrence of an event
AU2002342739A1 (en) Diffuser for active ingredients
AUPR272801A0 (en) An improved truss member and assembly

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP